|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2008-1-24
|
|
pubmed:abstractText |
Hidradenitis suppurativa is a chronic inflammatory skin disease characterized by abscess formation, predominantly in the axillae and groins. The disease is difficult to treat and has a severe impact on quality of life. Recently, several case reports have been published describing successful treatment of hidradenitis suppurativa with infliximab and other tumour necrosis factor alpha inhibitors.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0007-0963
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
158
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
370-4
|
|
pubmed:dateRevised |
2008-12-22
|
|
pubmed:meshHeading |
pubmed-meshheading:18047504-Adult,
pubmed-meshheading:18047504-Antibodies, Monoclonal,
pubmed-meshheading:18047504-Dermatologic Agents,
pubmed-meshheading:18047504-Female,
pubmed-meshheading:18047504-Follow-Up Studies,
pubmed-meshheading:18047504-Hidradenitis Suppurativa,
pubmed-meshheading:18047504-Humans,
pubmed-meshheading:18047504-Infusions, Intravenous,
pubmed-meshheading:18047504-Male,
pubmed-meshheading:18047504-Middle Aged,
pubmed-meshheading:18047504-Patient Satisfaction,
pubmed-meshheading:18047504-Quality of Life,
pubmed-meshheading:18047504-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Long-term efficacy of a single course of infliximab in hidradenitis suppurativa.
|
|
pubmed:affiliation |
Department of Dermatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. j.r.mekkes@amc.uva.nl
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
